Research
Hormonal
Time-restricted feeding does not significantly improve cardiometabolic markers (HDL, LDL, triglycerides) compared to control diets in overweight or obese adults.
Do not expect time-restricted feeding to automatically improve your cholesterol or triglyceride levels. While it helps with weight loss, you may need to focus on other dietary factors or exercise to improve your lipid profile.
GoodRefutesHIGH confidence
There was no significant change in HDL, LDL, or triglycerides comparing between TRF and control diet.
Why this rating
Systematic review and meta-analysis of RCTs.
Source
Effect of Time-Restricted Feeding on Body Weight and Cardiometabolic Risks: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Darin Ruanpeng et al. · Journal of the Endocrine Society · 2021
DOI 10.1210/jendso/bvab048.016
Meta-analysis · 4 studiesCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →